The plasticity of the association between mu-opioid receptor and glutamate ionotropic receptor N in opioid analgesic tolerance and neuropathic pain

European Journal of Pharmacology

Volumn 716, Issue 1-3, 2013, Pages 94-105

  Sańchez Blázquez, Pilar ^a   Rodriǵuez Muñoz, Maria ^a   Berrocoso, Esther ^b   Garzoń, Javier ^a  

^a INSTITUTO CAJAL   (Spain)

^b UNIVERSITY OF CÁDIZ   (Spain)

Author keywords

Allodynia analgesia; Analgesic tolerance; Glutamate ionotropic receptor n; Mu opioid receptor; Neuropathic pain

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANTIDEPRESSANT AGENT; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CLONIDINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GLUTAMATE IONOTROPIC RECEPTOR N; HISTIDINE TRIAD NUCLEOTIDE BINDING PROTEIN 1; IONOTROPIC RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; NARCOTIC ANALGESIC AGENT; NEURONAL NITRIC OXIDE SYNTHASE; NUCLEOTIDE BINDING PROTEIN; PROTEIN KINASE C GAMMA; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; WIN 55 212 2;

ANALGESIA; ANTINOCICEPTION; CARBOXY TERMINAL SEQUENCE; CHRONIC CONSTRICTION INJURY; CHRONIC PAIN; COMPLEX FORMATION; DOSE RESPONSE; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG TOLERANCE; EXPERIMENTAL MODEL; HUMAN; INFLAMMATION; MOLECULAR PATHOLOGY; NERVE CELL PLASTICITY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW;

ALLODYNIA; ANALGESIA; ANALGESIC TOLERANCE; GLUTAMATE IONOTROPIC RECEPTOR N; MU-OPIOID RECEPTOR; NEUROPATHIC PAIN;

ANALGESICS; ANIMALS; DRUG TOLERANCE; HUMANS; NEURALGIA; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID, MU;

EID: 84892520587     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.01.066     Document Type: Review

References (81)

1. Ardid, D., Jourdan, D., Mestre, C., Villanueva, L., Le, B.D., Eschalier, A., 1995. Involvement of bulbospinal pathways in the antinociceptive effect of clomipramine in the rat. Brain Res. 695, 253-256.
2. Arner, S., Meyerson, B.A., 1988. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33, 11-23.
3. Bilsky, E.J., Bernstein, R.N., Wang, Z., Sadee, W., Porreca, F., 1996a. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. J. Pharmacol. Exp. Ther. 277, 484-490.
4. Bilsky, E.J., Inturrisi, C.E., Sadee, W., Hruby, V.J., Porreca, F., 1996b. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective μ or δ opioid agonists in mice. Pain 68, 229-237.
5. Bird, G.C., Lash, L.L., Han, J.S., Zou, X., Willis, W.D., Neugebauer, V., 2005. Protein kinase A-dependent enhanced NMDA receptor function in pain-related synaptic plasticity in rat amygdala neurones. J. Physiol. 564, 907-921.
6. Bokoch, G.M., Diebold, B., Kim, J.S., Gianni, D., 2009. Emerging evidence for the importance of phosphorylation in the regulation of NADPH oxidases. Antioxid. Redox Signaling 11, 2429-2441.
7. Breivik, H., Collett, B., Ventafridda, V., Cohen, R., Gallacher, D., 2006. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur. J. Pain 10, 287-333.
8. 2+ levels in neuronal culture. Eur. J. Pharmacol. 219, 53-57.
9. Celerier, E., Rivat, C., Jun, Y., Laulin, J.P., Larcher, A., Reynier, P., Simonnet, G., 2000. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 92, 465-472.
10. 2+- calmodulin and protein kinase Cs: a hypothetical synthesis of their conflicting convergences on shared substrate domains. Trends Neurosci. 22, 12-16.
11. Chapman, V., Haley, J.E., Dickenson, A.H., 1994. Electrophysiologic analysis of preemptive effects of spinal opioids on N-methyl-D-aspartate receptor-mediated events. Anesthesiology 81, 1429-1435.
12. Chetkovich, D.M., Sweatt, J.D., 1993. nMDA receptor activation increases cyclic AMP in area CA1 of the hippocampus via calcium/calmodulin stimulation of adenylyl cyclase. J. Neurochem. 61, 1933-1942.
13. Cooper, D.M., 2003. Regulation and organization of adenylyl cyclases and cAMP. Biochem. J. 375, 517-529.
14. Dawson, V.L., Dawson, T.M., London, E.D., Bredt, D.S., Snyder, S.H., 1991. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88, 6368-6371.
15. Doyle, T., Bryant, L., Muscoli, C., Cuzzocrea, S., Esposito, E., Chen, Z., Salvemini, D., 2010. Spinal NADPH oxidase is a source of superoxide in the development of morphine-induced hyperalgesia and antinociceptive tolerance. Neurosci. Lett. 483, 85-89.
16. Draganic, P., Miletic, G., Miletic, V., 2001. Changes in post-tetanic potentiation of A-fiber dorsal horn field potentials parallel the development and disappearance of neuropathic pain after sciatic nerve ligation in rats. Neurosci. Lett. 301, 127-130.
17. Eisenach, J.C., Gebhart, G.F., 1995. Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats. Anesthesiology 83, 1046-1054.
18. Eisenberg, E., McNicol, E.D., Carr, D.B., 2006. Efficacy of mu-opioid agonists in the treatment of evoked neuropathic pain: systematic review of randomized controlled trials. Eur. J. Pain 10, 667-676.
19. Elliott, K., Minami, N., Kolesnikov, Y.A., Pasternak, G.W., Inturrisi, C.E., 1994. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain 56, 69-75.
20. Fu, Y., Han, J., Ishola, T., Scerbo, M., Adwanikar, H., Ramsey, C., Neugebauer, V., 2008. PKA and ERK, but not PKC, in the amygdala contribute to pain-related synaptic plasticity and behavior. Mol. Pain 4, 26.
21. Fundytus, M.E., 2001. Glutamate receptors and nociception: implications for the drug treatment of pain. CNS Drugs 15, 29-58.
22. Garzón, J., Rodríguez-Muñoz, M., López-Fando, A., Sánchez-Blázquez, P., 2005. Activation of μ-opioid receptors transfers control of Gα subunits to the regulator of G-protein signaling RGS9-2: role in receptor desensitization. J. Biol. Chem. 280, 8951-8960.
23. Garzón, J., Rodriguez-Muñoz, M., Sánchez- Blázquez, P., 2008. Do pharmacological approaches that prevent opioid tolerance target different elements in the same regulatory machinery? Curr. Drug Abuse Rev. 1, 222-238.
24. Garzón, J., Rodríguez-Muñoz, M., Vicente- Sánchez, A., Bailón, C., Martínez-Murillo, R., Sánchez-Blázquez, P., 2011. RGSZ2 binds to the neural nitric oxide synthase PDZ domain to regulate mu-opioid receptor-mediated potentiation of the N-methyl-D-aspartate receptor-calmodulin-dependent protein kinase II pathway. Antioxid. Redox Signaling 15, 873-887.
25. Ghelardini, C., Galeotti, N., Vivoli, E., Norcini, M., Zhu, W., Stefano, G.B., Guarna, M., Bianchi, E., 2008. Molecular interaction in the mouse PAG between NMDA and opioid receptors in morphine-induced acute thermal nociception. J. Neurochem. 105, 91-100.
26. Goff, J.R., Burkey, A.R., Goff, D.J., Jasmin, L., 1998. Reorganization of the spinal dorsal horn in models of chronic pain: correlation with behaviour. Neuroscience 82, 559-574.
27. Guang, W., Wang, H., Su, T., Weinstein, I.B., Wang, J.B., 2004. Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia. Mol. Pharmacol. 66, 1285-1292.
28. Guo, H., Huang, L.Y., 2001. Alteration in the voltage dependence of NMDA receptor channels in rat dorsal horn neurones following peripheral inflammation. J. Physiol. 537, 115-123.
29. Hao, J.X., Xu, X.J., 1996. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered nitric oxide synthase inhibitors. Pain 66, 313-319.
30. Herman, B.H., Vocci, F., Bridge, P., 1995. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction. Neuropsychopharmacology 13, 269-293.
31. Hylden, J.L., Thomas, D.A., Iadarola, M.J., Nahin, R.L., Dubner, R., 1991. Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. Eur. J. Pharmacol. 194, 135-143.
32. Ibi, M., Matsuno, K., Matsumoto, M., Sasaki, M., Nakagawa, T., Katsuyama, M., Iwata, K., Zhang, J., Kaneko, S., Yabe-Nishimura, C., 2011. Involvement of NOX1/NADPH oxidase in morphine-induced analgesia and tolerance. J. Neurosci. 31, 18094-18103.
33. Inoue, M., Mishina, M., Ueda, H., 2003. Locus-specific rescue of GluRε1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J. Neurosci. 23, 6529-6536.
34. 2+ transients in the rat substantia gelatinosa neurons after ligation of L5-L6 spinal nerves. Neuroreport 11, 4055-4061.
35. Iwata, H., Takasusuki, T., Yamaguchi, S., Hori, Y., 2007. NMDA receptor 2B subunit-mediated synaptic transmission in the superficial dorsal horn of peripheral nerve-injured neuropathic mice. Brain Res. 1135, 92-101.
36. Keith, D.E., Anton, B., Murray, S.R., Zaki, P.A., Chu, P.C., Lissin, D.V., Monteillet-Agius, G., Stewart, P.L., Evans, C.J., von, Z.M., 1998. mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol. Pharmacol. 53, 377-384.
37. Knapp, L.T., Klann, E., 2000. Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content. J. Biol. Chem. 275, 24136-24145.
38. Liu, X.G., Sandkuhler, J., 1995. Long-term potentiation of C-fiber-evoked potentials in the rat spinal dorsal horn is prevented by spinal N-methyl-D-aspartic acid receptor blockage. Neurosci. Lett. 191, 43-46.
39. Liu, X.J., Salter, M.W., 2010. Glutamate receptor phosphorylation and trafficking in pain plasticity in spinal cord dorsal horn. Eur. J. Neurosci. 32, 278-289.
40. Mao, J., Price, D.D., Mayer, D.J., 1995. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62, 259-274.
41. Martin, G., Nie, Z., Siggins, G.R., 1997. mu-Opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons. J. Neurosci. 17, 11-22.
42. Mayer, A., Szasz, B.K., Kiss, J.P., 2009. Inhibitory effect of antidepressants on the NMDA-evoked [(3)H]noradrenaline release from rat hippocampal slices. Neurochem. Int. 55, 383-388.
43. Mayer, D.J., Mao, J., Holt, J., Price, D.D., 1999. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc. Natl. Acad. Sci. USA 96, 7731-7736.
44. Mehta, A.K., Halder, S., Khanna, N., Tandon, O.P., Sharma, K.K., 2012. Antagonism of stimulation-produced analgesia by naloxone and N-methyl-D-aspartate: role of opioid and N-methyl-D-aspartate receptors. Hum. Exp. Toxicol. 31, 51-56.
45. Meller, S.T., Gebhart, G.F., 1993. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52, 127-136.
46. Mico, J.A., Ardid, D., Berrocoso, E., Eschalier, A., 2006. Antidepressants and pain. Trends Pharmacol. Sci. 27, 348-354.
47. Miletic, G., Miletic, V., 2000. Long-term changes in sciatic-evoked A-fiber dorsal horn field potentials accompany loose ligation of the sciatic nerve in rats. Pain 84, 353-359.
48. Millan, M.J., 2002. Descending control of pain. Prog. Neurobiol. 66, 355-474.
49. Mjellem, N., Lund, A., Hole, K., 1993. Reduction of NMDA-induced behaviour after acute and chronic administration of desipramine in mice. Neuropharmacology 32, 591-595.
50. Mori, H., Mishina, M., 1995. Structure and function of the NMDA receptor channel. Neuropharmacology 34, 1219-1237.
51. Ossipov, M.H., Harris, S., Lloyd, P., Messineo, E., 1990. An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates. J. Pharmacol. Exp. Ther. 255, 1107-1116.
52. Ossipov, M.H., Lopez, Y., Nichols, M.L., Bian, D., Porreca, F., 1995a. Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury. Neurosci. Lett. 199, 83-86.
53. Ossipov, M.H., Lopez, Y., Nichols, M.L., Bian, D., Porreca, F., 1995b. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. Neurosci. Lett. 199, 87-90.
54. Pasternak, G.W., Kolesnikov, Y.A., Babey, A.M., 1995. Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance. Neuropsychopharmacology 13, 309-313.
55. Portenoy, R.K., Hagen, N.A., 1990. Breakthrough pain: definition, prevalence and characteristics. Pain 41, 273-281.
56. Przewlocka, B., Dziedzicka, M., Lason, W., Przewlocki, R., 1992. Differential effects of opioid receptor agonists on nociception and cAMP level in the spinal cord of monoarthritic rats. Life Sci. 50, 45-54.
57. Przewlocka, B., Mika, J., Capone, F., Machelska, H., Pavone, F., 1999. Intrathecal oxotremorine affects formalin-induced behavior and spinal nitric oxide synthase immunoreactivity in rats. Pharmacol. Biochem. Behav. 62, 531-536.
58. Przewlocki, R., Parsons, K.L., Sweeney, D.D., Trotter, C., Netzeband, J.G., Siggins, G.R., Gruol, D.L., 1999. Opioid enhancement of calcium oscillations and burst events involving NMDA receptors and L-type calcium channels in cultured hippocampal neurons. J. Neurosci. 19, 9705-9715.
59. Przewlocki, R., Przewlocka, B., 2005. Opioids in neuropathic pain. Curr. Pharm. Des. 11, 3013-3025.
60. Psifogeorgou, K., Terzi, D., Papachatzaki, M.M., Varidaki, A., Ferguson, D., Gold, S.J., Zachariou, V., 2011. A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia. J. Neurosci. 31, 5617-5624.
61. Reynolds, I.J., Miller, R.J., 1988. Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc. Br. J. Pharmacol. 95, 95-102.
62. Rodríguez-Muñoz, M., de la Torre-Madrid, E., Gaitán, G., Sánchez-Blázquez, P., Garzón, J., 2007a. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons. Cell Signal 19, 2558-2571.
63. Rodríguez-Muñoz, M., de la Torre-Madrid, E., Sánchez-Blázquez, P., Garzón, J., 2007b. Morphine induces endocytosis of neuronal μ-opioid receptors through the sustained transfer of Gα subunits to RGSZ2 proteins. Mol. Pain 3, 19.
64. Rodríguez-Muñoz, M., Sánchez-Blázquez, P., Vicente-Sánchez, A., Bailón, C., Martín-Aznar, B., Garzón, J., 2011. The histidine triad nucleotide-binding protein 1 supports mu-opioid receptor-glutamate NMDA receptor cross-regulation. Cell Mol. Life Sci. 68, 2933-2949.
65. Rodríguez-Muñoz, M., Sánchez-Blázquez, P., Vicente-Sánchez, A., Berrocoso, E., Garzón, J., 2012. The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control. Neuropsychopharmacology 37, 338-349.
66. Rodríguez-Muñoz, M., Torre-Madrid, E., Sánchez- Blázquez, P., Wang, J.B., Garzón, J., 2008. NMDAR-nNOS generated zinc recruits PKCgamma to the HINT1-RGS17 complex bound to the C terminus of Mu-opioid receptors. Cell Signal 20, 1855-1864.
67. Salter, M.W., 2005. Cellular signalling pathways of spinal pain neuroplasticity as targets for analgesic development. Curr. Top. Med. Chem. 5, 557-567.
68. Salter, M.W., Kalia, L.V., 2004. Src kinases: a hub for NMDA receptor regulation. Nat. Rev. Neurosci. 5, 317-328.
69. Sánchez-Blázquez, P., Rodríguez-Muñoz, M., Bailón, C., Garzón, J., 2012. GPCRs promote the release of zinc ions mediated by nNOS/NO and the Redox transducer RGSZ2 protein. Antioxid. Redox Signal.
70. Sánchez-Blázquez, P., Rodríguez-Muñoz, M., de la Torre-Madrid, E., Garzón, J., 2009. Brain-specific Gαz interacts with Src tyrosine kinase to regulate Mu-opioid receptor-NMDAR signaling pathway. Cell Signal 21, 1444-1454.
71. Sánchez-Blázquez, P., Rodríguez-Muñoz, M., Garzón, J., 2010. Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling. PLoS One 5, e11278.
72. Sánchez-Blázquez, P., Rodríguez-Muñoz, M., Montero, C., de la Torre-Madrid, E., Garzón, J., 2008. Calcium/calmodulin-dependent protein kinase II supports morphine antinociceptive tolerance by phosphorylation of glycosylated phosducin-like protein. Neuropharmacology 54, 319-330.
73. Sandkuhler, J., Liu, X., 1998. Induction of long-term potentiation at spinal synapses by noxious stimulation or nerve injury. Eur. J. Neurosci. 10, 2476-2480.
74. Sansone, R.A., Sansone, L.A., 2008. Pain, pain, go away: antidepressants and pain management. Psychiatry (Edgmont.) 5, 16-19.
75. Schulz, S., Mayer, D., Pfeiffer, M., Stumm, R., Koch, T., Höllt, V., 2004. Morphine induces terminal μ-opioid receptor desensitization by sustained phosphorylation of serine-375. EMBO J. 23, 3282-3289.
76. Sigtermans, M.J., van Hilten, J.J., Bauer, M.C., Arbous, M.S., Marinus, J., Sarton, E.Y., Dahan, A., 2009. Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. Pain 145, 304-311.
77. Solodkin, A., Traub, R.J., Gebhart, G.F., 1992. Unilateral hindpaw inflammation produces a bilateral increase in NADPH-diaphorase histochemical staining in the rat lumbar spinal cord. Neuroscience 51, 495-499.
78. Tal, M., 1996. A novel antioxidant alleviates heat hyperalgesia in rats with an experimental painful peripheral neuropathy. Neuroreport 7, 1382-1384.
79. Trujillo, K.A., Akil, H., 1991. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251, 85-87.
80. Watanabe, Y., Saito, H., Abe, K., 1993. Tricyclic antidepressants block NMDA receptor-mediated synaptic responses and induction of long-term potentiation in rat hippocampal slices. Neuropharmacology 32, 479-486.
81. Woolf, C.J., Salter, M.W., 2000. Neuronal plasticity: increasing the gain in pain. Science 288, 1765-1769.